FDG-PET半定量参数对碳离子放疗I期非小细胞肺癌的预后意义
多因素分析显示仅MTV独立预测总生存和无进展生存,且腺癌与鳞癌的MTV中位数存在差异,提示风险分层可能需要组织学特异性切点值。
要点
- MTV是唯一独立预测OS和PFS的FDG PET/CT参数。
- 鳞癌MTV中位数显著高于腺癌(6.625 cm3 vs 0.2 cm3,p<0.01)。
- 腺癌与鳞癌可能需要不同的MTV切点值进行风险分层。
核心结论
- 在所有FDG PET/CT参数中,仅MTV对碳离子放疗的I期非小细胞肺癌具有独立预后能力。
- MTV的组织学差异可能需要在风险适应性治疗管理中加以考虑。
研究设计与样本
- 采用Cox比例风险回归分析评估FDG-PET参数(SUVmax、SUVpeak、SUVmean、MTV、TLG)及临床病理变量的预后价值。
- 使用Mann-Whitney检验比较腺癌与鳞癌之间显著参数的中位数,并基于中位数绘制Kaplan-Meier曲线。
主要发现
- 中位随访44.8个月,1/2/3年总生存率分别为94.9/84.3/70.8%,无进展生存率分别为82.1/69.2/58.4%,局部控制率分别为97.3/85.7/82.3%。
- 多因素分析显示年龄(HR 1.09,95%CI 1.0-1.19,p<0.05)和MTV(HR 4.83,95%CI 1.21-19.27,p<0.03)预测总生存。
- 仅MTV独立预测无进展生存(HR 5.3,95%CI 1.32-21.35,p<0.02)。
- 鳞癌MTV中位数显著高于腺癌(6.625 cm3 vs 0.2 cm3,p<0.01)。
关键数值与推荐
- 基于整体队列的单一MTV切点值在鳞癌中对PFS无显著意义(p>0.02)。
- 腺癌的MTV切点值0.2 cm3(p<0.03)和鳞癌的MTV切点值6.625 cm3(p<0.05)具有相关性。
临床怎么用
- 治疗前FDG PET/CT的MTV可用于I期非小细胞肺癌碳离子放疗的预后评估。
- 风险分层时需考虑组织学类型,腺癌与鳞癌可能适用不同的MTV切点值。
局限性
- 单中心研究,结论需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Prognostic significance of volumetric 18F-fluorodeoxyglucose (FDG) positron emission tomography/computer tomography (PET/CT) parameters in carbon-ion radiotherapy (C-ion RT) treated stage I non-small cell lung cancer, and need of histology-wise separate cut-off values for risk stratification were assessed. METHODS: Thirty-nine patients (29 men and 10 women, 71.9 ± 8.3 years) who underwent FDG PET/CT examinations before C-ion RT were retrospectively evaluated. FDG-PET parameters: standardized uptake values (SUVmax, SUVpeak, and SUVmean), metabolic tumor volume (MTV), and total lesion glycolysis (TLG), and clinicopathological variables were assessed for prognosis using Cox proportional hazards regression analysis. Mann-Whitney test compared medians of significant parameters between adenocarcinoma (AC) and squamous cell carcinoma (SCC), and Kaplan-Meier curves were plotted for median-based low- and high-risk groups. RESULTS: Median follow-up period was 44.8 months. 1/2/3-year overall survival (OS), progression-free survival (PFS) and local control (LC) rates were 94.9/84.3/70.8, 82.1/69.2/58.4 and 97.3/85.7/82.3%. Multivariate analysis revealed age (hazard ratio, HR: 1.09; 95% confidence interval, CI: 1.0-1.19, p < 0.05) and MTV (HR 4.83, 95% CI 1.21-19.27, p < 0.03) predicted OS, and only MTV predicted PFS (HR 5.3, CI 1.32-21.35, p < 0.02) independently. Compared with AC, SCC had higher MTV (median, 6.625cm3 vs 0.2 cm3, p < 0.01). Single MTV cut-off based on overall cohort was insignificant in SCC for PFS (p > 0.02); separate cut-offs of MTV, 0.2 cm3 for AC (p < 0.03) and 6.625 cm3 for SCC (p < 0.05) were relevant. CONCLUSION: Among all FDG PET/CT parameters, only MTV beared prognostic ability for stage I NSCLC treated with C-ion RT, and its histological variation may need consideration for risk-adapted therapeutic management.
引用
- Shrestha S, Higuchi T, Shirai K, et al. Prognostic significance of semi-quantitative FDG-PET parameters in stage I non-small cell lung cancer treated with carbon-ion radiotherapy. Eur J Nucl Med Mol Imaging. 2019. PMID: 31758225. doi:10.1007/s00259-019-04585-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。